HBV Seq2 aa:208-216
HBV Seq2 aa:208-216, a HBsAg derived CD8 epitope peptide, is studied as part of Large envelope protein from Hepatitis B virus[1].
Product Specifications
CAS Number
160214-63-1
UNSPSC
12352209
Target
HBV
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hbv-seq2-aa-208-216.html
Solubility
10 mM in DMSO
Smiles
CC(C)C[C@@H](C(O)=O)NC([C@H](CC(C)C)NC([C@H]1N(CCC1)C([C@H](CC(C)C)NC([C@H](CC2=CC=CC=C2)NC([C@H]3N(CCC3)C([C@H](CO)NC([C@H](CC(C)C)NC([C@@H](N)[C@@H](C)CC)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C52H85N9O11
Molecular Weight
1012.29
References & Citations
[1]Xie X, et, al. HBeAg Is Indispensable for Inducing Liver Sinusoidal Endothelial Cell Activation by Hepatitis B Virus. Front Cell Infect Microbiol. 2022 Jan 31;12:797915.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH030777 100 µg
Recombinant Human SERPINB9/PI-9 Protein (Baculovirus, His Tag)
Sign In for Pricing
View Details 
